Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma.

van de Schans, S A M

Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology May 2012 - 1280-1286 p. digital

Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't

1569-8041

10.1093/annonc/mdr411 doi


Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cause of Death
Cyclophosphamide--adverse effects
Disease Progression
Doxorubicin--adverse effects
Female
Humans
Lymphoma, Large B-Cell, Diffuse--drug therapy
Male
Neoplasm Staging
Netherlands--epidemiology
Prednisone--adverse effects
Registries--statistics & numerical data
Standard of Care
Survival Analysis
Treatment Outcome
Vincristine--adverse effects